[1]
2025. Evaluating Effectiveness of Deferasirox Versus Deferoxamine in Improving Clinical Outcomes among Patients with Transfusion-Dependent Thalassemia: A Randomized Controlled Trial. Link Medical Journal. 3, 2 (Dec. 2025), 1–12. DOI:https://doi.org/10.61919/e41dwh72.